XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Revenues:    
Total revenues $ 10,538,492 $ 10,032,641
Expenses:    
Cost of product revenues 7,629,467 8,541,574
Research and development 2,115,921 2,100,753
Selling, general and administration 4,701,061 7,231,865
Litigation damages 24,800,000
Total expenses 14,446,449 42,674,192
Loss from operations (3,907,957) (32,641,551)
Other income:    
Interest income 446,448 172,840
Other income (expense), net 324,934 (43)
Loss on impairment of investments, net (24,121)
Foreign currency transaction gains (losses) 99,163 (79,461)
Total other income 846,424 93,336
Loss before provision for income taxes (3,061,533) (32,548,215)
Tax provision (52,000)
Net loss $ (3,113,533) $ (32,548,215)
Net loss per share    
Basic $ (0.02) $ (0.27)
Diluted $ (0.02) $ (0.27)
Weighted average number of common shares outstanding    
Basic 166,118,010 120,114,985
Diluted 166,118,010 120,114,985
Net Product Revenues [Member]    
Revenues:    
Total revenues $ 9,229,885 $ 9,025,366
Research and Development Revenues [Member]    
Revenues:    
Total revenues 1,236,667 899,965
License and Other Revenues [Member]    
Revenues:    
Total revenues $ 71,940 $ 107,310